Loading organizations...
Loading organizations...
Developing new drugs for managing respiratory diseases.
Therabron has raised $17.9M across 2 funding rounds.
Therabron has raised $17.9M in total across 2 funding rounds.
Therabron has raised $17.9M in total across 2 funding rounds.
Therabron's investors include Brace Pharma Capital, Vinzenz Ploerer, Zell Biotech Two.
Therabron has raised $17.9M across 2 funding rounds. Most recently, it raised $6.8M Series B Extension in November 2015.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 9, 2015 | $6.8M Series B Extension | Brace Pharma Capital | |
| Dec 18, 2014 | $11.1M Series B | Vinzenz Ploerer, Zell Biotech Two |